alzheimer's semaglutide Details of failed studies cast pall on Novo Nordisk's GLP-1 as treatment semaglutide for alzheimer's Alzheimer's: Ozempic
Description
This is great news for older patients as well as healthcare professionals, as these results build on the importance of our randomized clinical trial data assessing the effectiveness of treatments in a real-life setting
What changes is the peak concentration and the absolute amount of drug present at any given time
Rare but important risks include pancreatitis, gallstones or gallbladder issues, and worsening of advanced diabetic eye disease in certain individuals
NAM Perspectives Discussion Paper, National Academy of Medicine, Washington, DC
Mistake 5: reusing needles to reduce waste Some researchers try to use the same needle to draw multiple doses before capping and storing, thinking this reduces vial septum punctures
A compliance-focused transition: shifting from risky compounded drugs toward partnerships to distribute branded, approved medications
